Wilson Ka Ming Wong

Wilson Ka Ming Wong

Auto-generated profile, based on publicly available information

Wilson Ka Ming Wong

Diabetes & Islet Biology Group, School of Medicine Western Sydney University Campbelltown New South Wales Australia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Cell Metabolism
Verified
Journal Article
Closed access
AHAnand Hardikar
Anand Hardikar
SSSarang N. Satoor
Sarang N. Satoor
MKMahesh S. Karandikar
Mahesh S. Karandikar
MJMugdha V. Joglekar
Mugdha V. Joglekar
APAmrutesh S. Puranik
Amrutesh S. Puranik
CYChittaranjan S. Yajnik
Chittaranjan S. Yajnik

3 April 2020 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
MJMugdha Joglekar
Mugdha Joglekar
SSSarang N. Satoor
Sarang N. Satoor
WWWilson K.M. Wong
Wilson K.M. Wong
FCFeifei Cheng
Feifei Cheng
RMRonald Ching Wan Ma
Ronald Ching Wan Ma
AHAnand Hardikar
Anand Hardikar
Telomeres represent the nucleotide repeat sequences at the ends of chromosomes and are essential for chromosome stability. They can shorten at each round of DNA replication mainly because of incomplete DNA synthesis of the lagging strand. Reduced relative telomere length is associated with aging and a range of disease states. Different methods such as terminal restriction fragment analysis, real-time quantitative PCR (qPCR) and fluorescence in situ hybridization are available to measure telomere length; however, the qPCR-based method is commonly used for large population-based studies. There are multiple variations across qPCR-based methods, including the choice of the single-copy gene, primer sequences, reagents, and data analysis methods in the different reported studies so far. Here, we provide a detailed step-by-step protocol that we have optimized and successfully tested in the hands of other users. This protocol will help researchers interested in measuring relative telomere lengths in cells or across larger clinical cohort/study samples to determine associations of telomere length with health and disease.

13 December 2018 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
WWWilson K. M. Wong
Wilson K. M. Wong
Anja SørensenAnja Sørensen
Anja Sørensen
MJMugdha Joglekar
Mugdha Joglekar
AHAnand Hardikar
Anand Hardikar
LDLouise Torp Dalgaard
Louise Torp Dalgaard
In this review, we provide an overview of the current knowledge on the role of different classes of non-coding RNAs for islet and β-cell development, maturation and function. MicroRNAs (miRNAs), a prominent class of small RNAs, have been investigated for more than two decades and patterns of the roles of different miRNAs in pancreatic fetal development, islet and β-cell maturation and function are now emerging. Specific miRNAs are dynamically regulated throughout the period of pancreas development, during islet and β-cell differentiation as well as in the perinatal period, where a burst of β-cell replication takes place. The role of long non-coding RNAs (lncRNA) in islet and β-cells is less investigated than for miRNAs, but knowledge is increasing rapidly. The advent of ultra-deep RNA sequencing has enabled the identification of highly islet- or β-cell-selective lncRNA transcripts expressed at low levels. Their roles in islet cells are currently only characterized for a few of these lncRNAs, and these are often associated with β-cell super-enhancers and regulate neighboring gene activity. Moreover, ncRNAs present in imprinted regions are involved in pancreas development and β-cell function. Altogether, these observations support significant and important actions of ncRNAs in β-cell development and function.

3 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AJAndrzej Januszewski
Andrzej Januszewski
YCYoon Hi Cho
Yoon Hi Cho
MJMugdha Joglekar
Mugdha Joglekar
RFRyan J. Farr
Ryan J. Farr
ESEmma S. Scott
Emma S. Scott
AJAlicia Jenkins
Alicia Jenkins
The aim of this cross-sectional study was to compare plasma C-peptide presence and levels in people without diabetes (CON) and with Type 1 diabetes and relate C-peptide status to clinical factors. In a subset we evaluated 50 microRNAs (miRs) previously implicated in beta-cell death and associations with clinical status and C-peptide levels. Diabetes age of onset was stratified as adult (≥ 18 y.o) or childhood (< 18 y.o.), and diabetes duration was stratified as ≤ 10 years, 10–20 years and > 20 years. Plasma C-peptide was measured by ultrasensitive ELISA. Plasma miRs were quantified using TaqMan probe-primer mix on an OpenArray platform. C-peptide was detectable in 55.3% of (n = 349) people with diabetes, including 64.1% of adults and 34.0% of youth with diabetes, p < 0.0001 and in all (n = 253) participants without diabetes (CON). C-peptide levels, when detectable, were lower in the individuals with diabetes than in the CON group [median lower quartile (LQ)–upper quartile (UQ)] 5.0 (2.6–28.7) versus 650.9 (401.2–732.4) pmol/L respectively, p < 0.0001 and lower in childhood versus adult-onset diabetes [median (LQ–UQ) 4.2 (2.6–12.2) pmol/L vs. 8.0 (2.3–80.5) pmol/L, p = 0.02, respectively]. In the childhood-onset group more people with longer diabetes duration (> 20 years) had detectable C-peptide (60%) than in those with shorter diabetes duration (39%, p for trend < 0.05). Nine miRs significantly correlated with detectable C-peptide levels in people with diabetes and 16 miRs correlated with C-peptide levels in CON. Our cross-sectional study results are supportive of (a) greater beta-cell function loss in younger onset Type 1 diabetes; (b) persistent insulin secretion in adult-onset diabetes and possibly regenerative secretion in childhood-onset long diabetes duration; and (c) relationships of C-peptide levels with circulating miRs. Confirmatory clinical studies and related basic science studies are merited.

23 March 2021 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MJMugdha Joglekar
Mugdha Joglekar
WWWilson K. M. Wong
Wilson K. M. Wong
FEFahmida K. Ema
Fahmida K. Ema
HGHarry Georgiou
Harry Georgiou
ASAlexis Shub
Alexis Shub
MLMartha Lappas
Martha Lappas

22 August 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
WWWilson K.M. Wong
Wilson K.M. Wong
GJGuozhi Jiang
Guozhi Jiang
Anja SørensenAnja Sørensen
Anja Sørensen
YCYi Vee Chew
Yi Vee Chew
CLCody Lee-Maynard
Cody Lee-Maynard
AHAnand Hardikar
Anand Hardikar
Human islet isolation is a cost- and resource-intensive program for generating islets for cell therapy in type 1 diabetes. However, only one-third of cadaveric pancreases get to clinical transplantation because of low quality/number of islets. There is a need to identify biomarkers that predict the quality of islets, before initiating their isolation. Here, we sequenced transcriptomes from 18 human islet preparations stratified into 3 groups (group 1: best quality/transplantable islets; group 2: intermediary quality; and group 3: inferior quality/nontransplantable islets) based on routine measurements, including islet purity/viability. Machine-learning algorithms involving penalized regression analyses identified 10 long noncoding RNAs (lncRNAs) that were significantly different across all group-wise comparisons (group 1 vs. group 2, group 2 vs. group 3, and group 1 vs. group 3). Two variants of metastasis-associated lung adenocarcinoma transcript 1 ( MALAT1 ) lncRNA were common across all comparisons. We then confirmed RNA-Seq findings in a validation set of 75 human islet preparations. Finally, in 19 pancreas samples, we demonstrated that assessing the levels of MALAT1 variants alone (receiver operator characteristic curve AUC: 0.83) offers higher specificity in predicting postisolation islet quality, further improving the predictive potential for clinical islet transplantation when combined with Edmonton Donor Points/BMI/North American Islet Donor Score. We present this resource of islet quality–stratified lncRNA transcriptome data and identify MALAT1 as a biomarker that significantly enhances current selection methods for clinical-grade (good manufacturing practice–grade) islet isolation.